tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Cash flow

Compare
25 Followers

Actuate Therapeutics, Inc. Cash Flow

ACTU's free cash flow for Q3 2025 was $-6.68M. For the 2025 fiscal year, ACTU's free cash flow was decreased by $-217.48K and operating cash flow was $-6.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22
Operating Cash Flow
$ -21.84M$ -21.63M$ -17.79M
Investing Cash Flow
$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 27.53M$ 4.13M$ 19.26M
End Cash Position
$ 8.64M$ 2.96M$ 20.45M
Free Cash Flow
$ -21.84M$ -21.63M$ -17.79M
Currency in USD

Actuate Therapeutics, Inc. Cash Flow